Most sales teams that enter healthcare underestimate it once and never make the same mistake twice. The buying process is unlike anything in the commercial world; it involves sprawling committees, clinical validation requirements, multi-year budget cycles, and compliance reviews that can pause a deal for months without warning. However, the firms that build durable, scalable revenue in healthcare have figured out that the problem is almost never the deal in front of them; the problem is everything behind it.
When your pipeline is thin and every active deal represents a disproportionate share of your number, long cycles become existential. When your pipeline is deep and consistently replenished, long cycles become manageable because you are never waiting on any single deal to save a quarter.
The Math Problem Nobody Is Talking About
There is a specific pattern that repeats itself endlessly in healthcare technology sales. A vendor lands a promising health system to deal, pours enormous energy into the evaluation, and eventually closes eighteen months after the first conversation. That deal consumed so much sales capacity that the pipeline behind it was completely neglected. The team is celebrating a close while staring at a nearly empty funnel.
McKinsey’s research on healthcare purchasing shows that health system technology evaluations routinely run six to twenty-four months. The math is straightforward and almost universally ignored:
If your average healthcare deal takes twelve months to close, you need twelve months of new pipeline being generated in parallel at all times just to maintain consistent revenue.
Most healthcare tech vendors are generating three months of pipeline behind a twelve-month deal.
The gap is where revenue collapses. The solution is a pipeline generation motion that runs independently of deal management, a dedicated outbound function of identifying, engaging, and qualifying new health system opportunities regardless of what is happening with active deals.
Understanding the Stakeholder Web
Within any active deal, healthcare buying demands multi-threaded engagement that most vendors manage poorly. A health system purchase involves:
Clinical staff evaluating workflow fit and patient impact.
IT is assessing integration capability and security posture.
Compliance reviewing HIPAA alignment and regulatory risk.
Finance building the ROI case and budget justification.
Department heads protecting their operational autonomy.
Vendors engaging multiple departments early face significantly shorter evaluation timelines than those moving stakeholders by stakeholders. A deal that appears to be progressing well with an IT director can be completely derailed by a compliance concern building for weeks in conversations the vendor was never part of. Multi-threaded engagement is the only way to have visibility into all the conversations shaping the outcome of the deal.
Running parallel workstreams across six or seven stakeholder groups inside a complex deal while simultaneously generating a new pipeline requires a level of organisational capacity most healthcare tech vendors simply do not have. The teams managing it successfully have made one structural decision: separate pipeline generation from deal management so that the reps navigating active evaluations are never also responsible for finding the next wave of opportunities.
Front-Loading Compliance
The compliance review is one of the most predictable and avoidable stall points in healthcare sales. Most vendors treat it as a back-end checklist; healthcare buyers treat it as a prerequisite. The vendors who remove this blocker proactively arrive at the first or second meeting with a complete package already prepared. That package should include:
HIPAA attestation and BAA template ready to share.
SOC 2 Type II certification (current, not pending).
Penetration testing results.
Data residency and encryption documentation.
HHS’s official guidance on HIPAA business associate requirements is the authoritative reference for understanding exactly what buyers are evaluating. Know this documentation better than your buyers do. The vendor that arrives with a complete compliance package signals organisational maturity that no product demo can replicate.
GPO Contracting and Clinical Evidence
Two often-overlooked tools that directly accelerate pipeline conversion in healthcare:
Group Purchasing Organisations: If your product is on an approved GPO contract, health systems can often procure without a full competitive bid process. The timeline compression this enables, from eighteen months to sixty days in some cases, means the pipeline generation investment that brought deals in converts to revenue dramatically faster.
Clinical Evidence: Healthcare buyers are trained sceptics who have been promised cost reductions by every vendor who has walked in the door. Published outcomes data and referenceable case studies from comparable health systems carry more weight than any sales presentation. The Agency for Healthcare Research and Quality maintain a library of evidence-based resources that vendors can align with when building their clinical case. Build this evidence library before you desperately need it, because when you need it, you will not have time to build it.
Conclusion
Healthcare sales is ultimately a volume and velocity problem disguised as a complexity problem. The teams that solve it are the ones who build a pipeline generation engine that runs continuously behind their active deals, so that no single evaluation, regardless of how long it takes, can destabilise the business. The Point Co helps healthcare technology vendors build exactly this kind of outbound pipeline infrastructure, generating a consistent flow of qualified health system opportunities that keep revenue predictable even when individual cycles run long.